Sirtex, Guerbet collaborate on clinical studies in liver cancer

Monday, March 24, 2014

Sirtex Medical, a global life sciences company, and Guerbet, a pharmaceutical group dedicated to medical imaging worldwide, are collaborating to advance research in primary and secondary metastatic liver cancer. The objective is to evaluate the unmet clinical need in patients with hepatocellular carcinoma, metastatic colorectal cancer, neuroendocrine tumors and a range of other secondary liver cancers.

[Read More]

Demonsang, Tobelem join OSE Pharma board, Peyroles named CFO

Wednesday, November 13, 2013

OSE Pharma, dedicated to severe and orphan lung diseases, has announced the nomination of two new board members with a broad international experience and the recruitment of a CFO from the healthcare industry. These appointments are part of the plan to launch phase III of its targeted lung cancer immunotherapy product.

[Read More]